OncoLink at ASCO 1998: Tuesday May 19

Chemical Derived from Naturally-Occurring Mold May Slow Growth of Metastatic Kidney Cancer by Inhibiting Growth of Tumor Blood Supply
New Antisense Agent Stops Production of Cancer-Causing Protein
Older Breast Cancer Patients can Tolerate Adjuvant Therapy with Doxorubicin and Cyclophosphamide
Primary Breast Cancers are Reduced by Raloxifene
Six-Month Chemotherapy Regimen for Colon Cancer Replaces Conventional 12-Month Regimen
Standard Chemotherapy Shows Increased Toxicity for Elderly with Node-Positive Breast Cancer

Soft Tissue Sarcoma Therapy Limb Salvage Rate 81 Percent

Sep 22, 2011 - Tumor necrosis factor-α and melphalan-based isolated limb perfusion therapy has a limb salvage rate of 81 percent in patients with locally advanced extremity soft tissue sarcomas who would have otherwise undergone amputation, according to a study published online Sept. 19 in the Journal of Clinical Oncology.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More